Watch results video
Headline revenue of £35.6m (FY20: £30.3m), up 17.6% (up 19.9% on a constant currency basis)
Adjusted Profit Before Tax* up 89.4% at £4.8m (FY20: £2.6m)
Annual Recurring Revenue
Improved quality of earnings, with Annual Recurring Revenue (‘ARR’) of £7.4m (FY20: £6.8m) with new ARR additions of £1.3m (FY20: £1.0m)
Continued cash generation, with £23.0m in net cash (FY20: £14.9m) and operating cashflow of £14.5m (FY20: £7.0m - Restated)
The Group is pleased to report a strong full year performance in 2020/21 and a return to form following last year’s pandemic-impacted trading. The business has demonstrated its resilience during the period and signs of accelerating market trends commented on last year are now being realised. Furthermore, we have emerged from the challenges over the past 18 months with an even stronger financial platform to fund organic growth and expedite potential acquisition opportunities.
Without exception, the key financial metrics of the business have improved with the Group reporting revenue of £35.6m (FY20: £30.3m), a statutory PBT of £3.2m (FY20: £1.6m), an Adjusted PBT* of £4.8m (FY20: £2.6m), cash generated from operating activities £14.5m (FY20: £7.0m - Restated) and a cash position of £23.0m (FY20: £14.9m). We also continued to enhance the quality of our earnings by increasing our Annual Recurring Revenue (‘ARR’) to £7.4m (FY20: £6.8m).
We have emerged from the challenges over the past 18 months with an even stronger financial platform to fund organic growth and expedite potential acquisition opportunities.
Adjusted PBT* (£'000)
Recurring Revenues (£'000)
Cash Generation after Tax (£'000)
Ordinary Dividends paid (p)
Annual TSR*** (%)
*Profit Before Tax before Group recharges adjusted for share-based payments, amortisation and impairment of intangibles arising on acquisition, fair value adjustments to IMeasureU purchase consideration, impairment of Pimloc investment and exceptional costs.
**Earnings Per Share (EPS).
***Total Shareholder Return (TSR) Cumulative
Growth Rate (CAGR) of 21% over the period.
The key financials of the investor area on oxfordmetrics.com contains financial information about Oxford Metrics which has been provided for general information only. You should not take action in reliance of such information but rather make your own independent enquiries and seek the advice of a relevant professional.
Annual and Interim Results
Financial calendar 2022
Annual General Meeting
Proposed dividend payment
End of H1
End of financial year